AstraZeneca PLC (AZN)'s Antibiotics Alums Emerge at Biotech Spinout Entasis Therapeutics
GlaxoSmithKline (GSK) Will Receive $140B+ Bid in Q4, From Suitors Including Pfizer (PFE) and AstraZeneca PLC (AZN): Poll
Seattle’s Adaptive Biotech Will Set Up Shop in New York
Baxter International (BAX) Spinout Baxalta Finally Has Long Awaited Launch
Feds Want Novartis AG (NVS) to Fork Over $3.35 Billion for Kickback Schemes
GlaxoSmithKline (GSK) Discloses $175K Paid to Hundreds of North Carolina Doctors
Evotec AG (EVTG.F), Roche (RHHBY)'s Alzheimer's Hopeful Fails Another Trial
Sarepta (SRPT) Bags Ex-Genzyme (GENZ) CEO as Advisor to the Company
EXCLUSIVE: Gene Therapy M&A Booms, Increasing 40-Fold to $4.9 Billion
EXCLUSIVE: Juno Therapeutics (JUNO)/Celgene (CELG) Deal "Great Validation" for Cellular Therapy, TxCell CEO Tells BioSpace (DHX)
Genentech (RHHBY)'s Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market
Juno Therapeutics (JUNO) Stock Soars After Celgene (CELG) Acquires $1 Billion Stake in Seattle Company
Vertex (VRTX) Poised to Become Profitable Following Expected FDA Approval of Orkambi
New Sarepta (SRPT) CEO's Strategy Bears Fruit With NDA Filing
Amgen (AMGN) To Lay Off 330 in Colorado as Part of Almost 4,000 Jobs Cuts Overall
Hikma (HIK.L) Rumored to Be Bidding $2.2B for Boehringer Ingelheim's Roxane Laboratories, As Mallinckrodt (MNK), Perrigo (PRGO) Circle
Two Yale University Health Info Groups Sue FDA, Gilead (GILD) for Hep C Drug Trial Data
AstraZeneca PLC (AZN), Eolas Forge $145M+ Pact On Smoking Cessation Plan
See All News >
//-->